At the very time when the Ad- ministration is pressing for an in- crease of $100 million in Federal expenditures for the conquest of cancer, a shortage of cytotechnologists, who are valuable in re- search as well as control, may occur.When Congress passed the Partnership for Health Act and section 314E became effective in June 1970, cancer was among the categorical diseases that lost
Kenneth S. DeffeyesM. Silverman